Sucampo Pharmaceuticals, Inc. (SCMP) Reports Q3 Loss of $0.10, Sales Miss Expectations
Tweet
Share
E-mailGet Alerts SCMP Hot Sheet
Price: $18.00 --0%
Financial Fact:
Net income (loss): 8.09M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Financial Fact:
Net income (loss): 8.09M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) reported Q3 EPS of ($0.10), versus $0.05 reported last year. Revenue for the quarter came in at $14.37 million, versus $20.9 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Business First Bancshares, Inc. (BFST) Misses Q1 EPS by 7c
- Northeast Community Bancorp, Inc. (NECB) Tops Q1 EPS by 12c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
